Health Aug 19 FDA blocks much-anticipated BioMarin hemophilia gene therapy By Linda A. Johnson, Associated PRess
Science Mar 04 Gene therapy was a boy’s last chance to stop leukemia. And it worked. At least 50 children are in remission because of a breakthrough treatment that engineers the body’s own immune system to fight cancer. By Lesley McClurg, KQED Science
Health Jan 14 At $850,000, price for new childhood blindness gene therapy four times too high, analysis says Luxturna, a gene therapy with a list price $850,000, is the latest flashpoint in the debate over how to afford innovative medicines. By Andrew Joseph, STAT
Health Oct 15 We may soon have our first $1 million drug. Who will pay for it? And how? As the first gene therapies approach the market, drug makers, insurers, and patients are debating complex questions about cost, value, and payment plans. By Meghana Keshavan, STAT
Health Aug 30 U.S. clears first ‘gene therapy’ for tough childhood leukemia Opening a new era in cancer care, the Food and Drug Administration on Wednesday approved the first treatment that genetically engineers patients' own blood cells into an army of assassins to seek and destroy childhood leukemia. By Lauran Neergaard, Associated Press
May 18 Watch Mapping the Genomes of Crocodiles and Alligators Science Nation video mapping genomes of alligators crocodiles and bats… Continue watching
Dec 08 Questions and Answers with Dr. Kathy Zoon By PBS NewsHour Dr. Kathy Zoon of the federal Food and Drug Administration oversees the roughly 200 gene therapy clinical trials now underway in the United States. Continue reading